Clinical Trial Update: Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy

View source ↗

Summary

This clinical trial aims to analyze genomic data to identify a predictive biomarker for immunotherapy in lung cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Se-Hoon Lee | Conditions: Lung Cancer | Status: RECRUITING